GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Can B Corp (OTCPK:CANB) » Definitions » Interest Coverage

Can B (CANB) Interest Coverage : 0 (At Loss) (As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Can B Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Can B's Operating Income for the three months ended in Sep. 2024 was $-2.83 Mil. Can B's Interest Expense for the three months ended in Sep. 2024 was $-0.43 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Can B's Interest Coverage or its related term are showing as below:


CANB's Interest Coverage is not ranked *
in the Drug Manufacturers industry.
Industry Median: 12.45
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Can B Interest Coverage Historical Data

The historical data trend for Can B's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Can B Interest Coverage Chart

Can B Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Coverage
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Can B Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Can B's Interest Coverage

For the Drug Manufacturers - Specialty & Generic subindustry, Can B's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Can B's Interest Coverage Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Can B's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Can B's Interest Coverage falls into.


;
;

Can B Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Can B's Interest Coverage for the fiscal year that ended in Dec. 2023 is calculated as

Here, for the fiscal year that ended in Dec. 2023, Can B's Interest Expense was $-2.51 Mil. Its Operating Income was $-7.49 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.00 Mil.

Can B did not have earnings to cover the interest expense.

Can B's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as

Here, for the three months ended in Sep. 2024, Can B's Interest Expense was $-0.43 Mil. Its Operating Income was $-2.83 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.00 Mil.

Can B did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Can B  (OTCPK:CANB) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Can B Interest Coverage Related Terms

Thank you for viewing the detailed overview of Can B's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Can B Business Description

Traded in Other Exchanges
N/A
Address
960 South Broadway, Suite 120, Hicksville, NY, USA, 11801
Can B Corp is engaged in the business of promoting health and wellness through its development, manufacture and sale of products containing cannabinoids derived from hemp biomass and the licensing of durable medical devices. The company focuses on developing a line of proprietary products in the Hemp Industry.
Executives
Mckenzie Webster Ltd 10 percent owner DMS HOUSE, DR. ROYCE DRIVE, GEORGE TOWN, GRAND CAYMAN E9 KY1-1102
Stanley L Teeple director, officer: CFO, Director, and Secretary 94 ARTHUR HILL COURT, HENDERSON NV 89014
Andrew Holtmeyer officer: EVP Business Development 65 LAUREN AVE, SUITE 301, HUNTINGTON STATION NY 11746
Heggenhougen Rolv director 90 NORTH CHURCH STREET, GEORGETOWN E9 KY1-1102
David J Posel officer: COO 6103 CARMEL LN SE, LACEY WA 98503
Rolv Heggenhougen 10 percent owner 445 NE 12TH AVENUE, FORT LAUDERDALE FL 33301
Marco Alfonsi director, 10 percent owner, officer: CEO, Board Member 44 EAST END AVENUE, HICKSVILLE NY 11801
Carl Dilley director 15500 ROOSEVELT BLVD., SUITE 301, CLEARWATER FL 33760

Can B Headlines

From GuruFocus

Four Cannabis Companies Capitalizing On Increased CBD Demand

By Marketwired Marketwired 08-18-2021

Can B Corp At Emerging Growth Conference Transcript

By GuruFocus Research 02-13-2024